Years of life lived by elderly Singaporeans with and without frailty REVES@30 University of Michigan, Ann Arbor 1 st June 2018 Rahul Malhotra 1 , Abhijit Visaria 1 , Choy-Lye Chei 1 , Chi-Tsun Chiu 2 , John Carson Allen 1 , Stefan Ma 3 , Chek Hooi Wong 4 , Angelique Chan 1 , Yasuhiko Saito 5 , Truls Østbye 1 , David Bruce Matchar 1 1 Duke-NUS Medical School, Singapore 2 Academia Sinica, Taipei, Taiwan 3 Ministry of Health, Singapore 4 Khoo Teck Puat Hospital, Singapore 5 Nihon University, Tokyo, Japan
32
Embed
Years of life lived by elderly Singaporeans with and without frailty · 2018. 6. 12. · Years of life lived by elderly Singaporeans with and without frailty. REVES@30. University
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Years of life lived by elderly Singaporeans with and without frailty
REVES@30University of Michigan, Ann Arbor
1st June 2018
Rahul Malhotra1, Abhijit Visaria1, Choy-Lye Chei1, Chi-Tsun Chiu2, John Carson Allen1, Stefan Ma3, Chek Hooi Wong4, Angelique Chan1, Yasuhiko Saito5, Truls Østbye1, David Bruce Matchar1
1Duke-NUS Medical School, Singapore 2Academia Sinica, Taipei, Taiwan3Ministry of Health, Singapore4Khoo Teck Puat Hospital, Singapore5Nihon University, Tokyo, Japan
Content
• Singapore
• Frailty, and the Frailty Assessment Measure (FAM)
Duration of life lived with and without frailty
Motivation
Methods
Results
Discussion
2
Singapore – Demographic Profile
3
Population, 2017: 5.61 million (Resident=3.97 million, Non-resident=1.64 million)
Populations Trend 2017, Department of Statistics Singapore, 2017
Source: United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision, custom data acquired via website.
Proportion of population aged 65+
Frailty: Definition(s)
6
A clinical state in which there is an increase in an individual’s risk for developing increased dependency and/or mortality when exposed to a stressor
A dynamic state affecting an individual who experiences losses in one or more domains of human functioning (physical, psychological and social), which is caused by a range of variables, and which increases the risk of adverse health outcomes
• Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. Journal of the American Medical Directors Association 2013;14:392-7.• de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Nijhuis-van der Sanden MW. Outcome instruments to measure frailty: a systematic review. Ageing research reviews 2011;10:104-14.
Frailty Assessment Measure (FAM)
7
ROBUST PRE-FRAIL FRAIL
< 0.38 0.38 to 0.82 > 0.82
• Body mass index* (1 item)• Hand grip strength* (1 item)• Mobility (9 items)
• Age (1 item)• Gender (1 item)• Number of chronic health conditions (1 item)
14-item measure
* measured
Content
• Singapore
• Frailty, and the Frailty Assessment Measure (FAM)
Duration of life lived with and without frailty
Motivation
Methods
Results
Discussion
8
Duration of life lived with and without frailty: Motivation
• Frailty, among the elderly, is highlighted by clinical professional bodies and health organizations as an important clinical state, calling for early detection
• The policy importance of, and clinical screening utility for, frailty, however, depend on the duration of life an average elderly lives with frailty
• Only 2 publications, from Europe, have estimated this duration• Herr et al 2017: At age 70, women spend 3.4 (19%) and 2.4 (14%) years of remaining life with frailty and
disability. Corresponding estimates for men were 1.2 (9%) and 1.2 (9%) years. Years lived with pre-frailty (7.4 [41%] for women and 6.0 [41%] for men) were greater. (Frailty based the Cardiovascular Health Study [CHS] ~ Fried construct)
• Romero-Ortuno et al 2014: In the EU27, at age 50, women spend 2.1 (6%) and 7.4 (21%) years of remaining life with frailty and severe limitations. Corresponding estimates for men were 0.8 (3%) and 5.1 (17%) years. (Frailty based the Cardiovascular Health Study [CHS] ~ Fried construct)
9
Aim and Hypothesis
Utilizing longitudinal data from a national survey of the elderly in Singapore, we aim to estimate the duration of life lived with and without frailty for elderly Singaporeans, overall and by gender
Hypothesis
At age 60 (and 70 and 80) the absolute (i.e. number of years) and relative (i.e. proportion of remaining life) duration of life lived with frailty is higher for women versus men
10
Dataset
• Panel on Health and Aging of Singaporean Elderly (PHASE)
• Nationally representative longitudinal survey of home-dwelling elderly Singaporeans (Stratified Random Sampling)
Frailty Assessment Measure (FAM), based on data collected in the Wave
Based on data on 7 ADLs collected in the Wave
Based on data on status (Alive / Dead) collected in the Wave, with Date of Death from administrative databases
5. Dead
1. Robust 2. Pre-frail 3. Frail 4. ADL Limitation
Potential transitions across health states, across wavesAnalysis: SPACE (Stochastic Population Analysis for Complex Events) http://sites.utexas.edu/space/
Total Life Expectancy (TLE) 7.9 (7.2, 8.7) 10.6 (9.8, 11.4) -2.7 (-3.6 , -1.5)
Singapore Life Table 2012 TLE 8.7 10.4 - 6.40.6
60.8
44.5
9.0
19.1
23.8
35.8
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Men Women
Prop
ortio
n of
rem
aini
ng li
fe a
t age
80
Robust Pre-Frail
Frail ADL Limitation
Conclusions and Implications
• At age 60 (and 70 and 80), despite their higher total life expectancy, women, versus men, spend:fewer years in a robust state, and more years in the pre-frail, frail, and ADL limitation states
• Support for a priori hypothesis: Women’s disadvantage in health expectancy, often reported for disability or for ADL limitations, is also manifested in context of frailtyAlso observed in health states (robust and pre-frail) preceding frailty and ADL
limitationCalls for greater and earlier attention to women’s health
22
Conclusions and Implications
• Short absolute (1, 1.2 and 1.4 years, respectively) or relative (~4%, 7% and 15%) duration of remaining life at age 60, 70 and 80 spent in a frail state:Consistent with previous reportsQuestions the policy and clinical focusing on frailty among older adults, but suggests
that increased attention should be placed on pre-frailty
23
Limitations
• Sample size for some of the observed transitions
• 2 and 4 year interval between survey waves
• Measure used for frailty
24
Strengths
• Measure used for frailty
• Mortality assessment from administrative databases
• Singapore! Asia!
25
Future work
• Strata defined by ethnicity and by educational status
• Simulated lifelines: Duration spent in a specific state
• Potential replication of analyses in other cohort studies in Singapore (and elsewhere in Asia)
• Trends (fresh cohort – THE SIGNS Study established [Wave 1 in 2016/17; Wave 2 in 2018/19; …….$])
26
27
• Ministry of Social and Family Development, Singapore. • Singapore Ministry of Health’s National Medical Research Council under its Singapore Translational Research Investigator Award as part of the project “Establishing a
Practical and Theoretical Foundation for Comprehensive and Integrated Community, Policy and Academic Efforts to Improve Dementia Care in Singapore” (NMRC-STAR-0005-2009)
• Singapore Ministry of Health’s National Medical Research Council under its Clinician Scientist – Individual Research Grant - New Investigator Grant (NMRC-CNIG-1124-2014)
• Duke-NUS Geriatric Research Fund • Funding for dynamometers was through a grant obtained by the Nihon University Population Research Institute from the “Academic Frontier” Project for Private
Universities: matching fund subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), 2006-2010.
Funding for Panel on Health and Ageing of Singaporean Elderly (PHASE) Waves 1, 2 and 3
• Singapore Ministry of Health’s National Medical Research Council under its Clinician Scientist – Individual Research Grant - New Investigator Grant (NMRC-CNIG-1124-2014)
• Centre for Ageing Research & Education, Duke-NUS Medical School, Singapore
BMI: Body Mass Index; SE: Standard Error a Continuous variable***p<0.01
β coefficient (SE)
Intercept 0.37 (2.89)
Frailty variables
ln BMIa -6.75 (2.31)***
BMIa^0.5 2.79 (0.92)***
Hand Grip Strength Ranka 0.04 (0.01)***
Nagi Index Scorea^2 0.12 (0.02)***
Nagi Index Scorea^3 -0.01 (0.003)***
Number of Chronic Health Conditionsa 0.25 (0.03)***
Agea (in years) 0.07 (0.005)***
Male Sex 0.58 (0.07)***
Association with a composite adverse health outcome - death or incident limitation in ≥1 ADL or prolonged hospitalization or frequent hospitalization or frequent emergency room visits (N=4564)
Predicted probability of the composite adverse outcome based on the FAM measure logistic regression coefficients
Predicted probability of the composite adverse outcome = 𝒆𝒆𝒙𝒙